Celltrion
068270.KS
#725
Rank
NZ$49.38 B
Marketcap
$226.28
Share price
1.19%
Change (1 day)
4.13%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.92

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $5.21. In 2022 the company made an earnings per share (EPS) of $5.07 a decrease over its 2021 EPS that were of $6.03.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.92-3.06%
2022$5.07-15.84%
2021$6.0312.77%
2020$5.3570.79%
2019$3.1315.63%
2018$2.71-33.13%
2017$4.05141.17%
2016$1.688.28%
2015$1.5511.28%
2014$1.3916.37%
2013$1.20-67.42%
2012$3.6884.22%
2011$2.0062.13%
2010$1.2380.61%
2009$0.68-559.63%
2008-$0.15-123.16%
2007$0.64